日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Pathological complete response with neoadjuvant pembrolizumab and chemotherapy in non-metastatic triple-negative inflammatory breast cancer

新辅助帕博利珠单抗联合化疗治疗非转移性三阴性炎性乳腺癌,达到病理完全缓解

Lynce, F; Valenza, C; Niman, S M; Bertucci, F; Kai, M; Ryan, S; Troll, E; Layman, R M; Fanucci, K A; Giordano, A; Nasrazadani, A; Nakhlis, F; Bellon, J; Warren, L; Block, C; Schumer, S; Lucci, A; Krishnamurthy, S; Trapani, D; Lerebours, F; Dalenc, F; Levy, C; Petit, T; Leheurteur, M; Bachelot, T; Tredan, O; Ribeiro, J M; Pistilli, B; Zagami, P; Ladoire, S; Lopez Almeida, L; Zemmour, C; Carey, L A; Tolaney, S M; Valero, V; Curigliano, G; Regan, M M; Goncalves, A; Woodward, W A

Mutation type, tyrosine kinase function in normal cell and tyrosine kinase inhibitor activity in cancers

突变类型、酪氨酸激酶在正常细胞中的功能以及酪氨酸激酶抑制剂在癌症中的活性

Vanacker, H; Cassier, P A; Dufresne, A; Pérol, M; Verlingue, Loic; Swalduz, A; Vinceneux, A; Attignon, V; Brahmi, M; Tredan, O; Tirode, F; Blay, J -Y

Causal analyses of the impact of comorbid conditions and concomitant medications on response to neoadjuvant chemotherapy in breast cancer: analysis of a multicenter prospective cohort study (CANTO)

合并症和伴随用药对乳腺癌新辅助化疗疗效影响的因果分析:一项多中心前瞻性队列研究(CANTO)的分析

Hamy, A-S; Grandal, B; Jochum, F; Dumas, É; Sella, N; Kassara, A; Barraud, S; Dubois, T; Ballesta, A; Everhard, S; Lemonnier, J; Sauzey, M; Bertaut, A; Blay, J-Y; Cottu, P; Tredan, O; Joly, F; Gougis, P; Asselain, B; Latouche, A; Vaz Luis, I; Andre, F; Reyal, F

Prognostic Value of a Joint K-PD Model With Tumor Size Dynamics and CA-125 Kinetics in Recurrent Ovarian Cancer Patients: BOLD Phase II GINECO Study

结合肿瘤大小动态和 CA-125 动力学的 K-PD 联合模型在复发性卵巢癌患者中的预后价值:BOLD II 期 GINECO 研究

Carrot, Aurore; Corbaux, Pauline; Colomban, Olivier; Lebreton, Coriolan; Gladieff, Laurence; Tredan, Olivier; Selle, Frédéric; Abdeddaim, Cyril; Leary, Alexandra; D'Hondt, Véronique; Dubot, Coraline; Reverdy, Thibaut; You, Benoit; Freyer, Gilles

Dose/Exposure Relationship of Exercise and Distant Recurrence in Primary Breast Cancer

运动与原发性乳腺癌远处复发的剂量/暴露关系

Soldato, Davide; Michiels, Stefan; Havas, Julie; Di Meglio, Antonio; Pagliuca, Martina; Franzoi, Maria Alice; Pistilli, Barbara; Iyengar, Neil M; Cottu, Paul; Lerebours, Florence; Coutant, Charles; Bertaut, Aurélie; Tredan, Oliver; Vanlemmens, Laurence; Jouannaud, Christelle; Hrab, Iona; Everhard, Sibille; Martin, Anne-Laure; André, Fabrice; Vaz-Luis, Ines; Jones, Lee W

Bevacizumab, olaparib, and durvalumab in patients with relapsed ovarian cancer: a phase II clinical trial from the GINECO group

贝伐珠单抗、奥拉帕尼和度伐利尤单抗治疗复发性卵巢癌患者:GINECO 研究组的一项 II 期临床试验

Freyer, Gilles; Floquet, Anne; Tredan, Olivier; Carrot, Aurore; Langlois-Jacques, Carole; Lopez, Jonathan; Selle, Frédéric; Abdeddaim, Cyril; Leary, Alexandra; Dubot-Poitelon, Coraline; Fabbro, Michel; Gladieff, Laurence; Lamuraglia, Michele

Author Correction: Bevacizumab, olaparib, and durvalumab in patients with relapsed ovarian cancer: a phase II clinical trial from the GINECO group

作者更正:贝伐珠单抗、奥拉帕尼和度伐利尤单抗治疗复发性卵巢癌患者:GINECO 研究组的 II 期临床试验

Freyer, Gilles; Floquet, Anne; Tredan, Olivier; Carrot, Aurore; Langlois-Jacques, Carole; Lopez, Jonathan; Selle, Frédéric; Abdeddaim, Cyril; Leary, Alexandra; Dubot-Poitelon, Coraline; Fabbro, Michel; Gladieff, Laurence; Lamuraglia, Michele

Neoadjuvant and adjuvant pembrolizumab in advanced high-grade serous carcinoma: the randomized phase II NeoPembrOV clinical trial

新辅助和辅助帕博利珠单抗治疗晚期高级别浆液性癌:随机 II 期 NeoPembrOV 临床试验

Ray-Coquard, Isabelle L; Savoye, Aude-Marie; Schiffler, Camille; Mouret-Reynier, Marie-Ange; Derbel, Olfa; Kalbacher, Elsa; LeHeurteur, Marianne; Martinez, Alejandra; Cornila, Corina; Martinez, Mathilde; Bengrine Lefevre, Leila; Priou, Frank; Cloarec, Nicolas; Venat, Laurence; Selle, Frédéric; Berton, Dominique; Collard, Olivier; Coquan, Elodie; Le Saux, Olivia; Treilleux, Isabelle; Gouerant, Sophie; Angelergues, Antoine; Joly, Florence; Tredan, Olivier

Collective responses of flocking sheep (Ovis aries) to a herding dog (border collie)

羊群(Ovis aries)对牧羊犬(边境牧羊犬)的集体反应

Jadhav, Vivek; Pasqua, Roberto; Zanon, Christophe; Roy, Matthieu; Tredan, Gilles; Bon, Richard; Guttal, Vishwesha; Theraulaz, Guy

TEDOVA: vaccine OSE2101 +/- pembrolizumab as maintenance in platinum-sensitive recurrent ovarian cancer

TEDOVA:疫苗 OSE2101 +/- 帕博利珠单抗作为铂敏感复发性卵巢癌的维持治疗

Kabirian, Rayan; Tredan, Olivier; Marmé, Frederik; Paoletti, Xavier; Eberst, Lauriane; Lebreton, Coriolan; De La Motte Rouge, Thibault; Sabatier, Renaud; Angelergues, Antoine; Fabbro, Michel; Van Gorp, Toon; Mansi, Laura; Gladieff, Laurence; Kaczmarek, Emilie; Alexandre, Jérôme; Grellety, Thomas; Favier, Laure; Welz, Julia; Frenel, Jean-Sébastien; Leary, Alexandra